Construction of complex three-dimensional vascularized liver tissue model in vitro based on a biphasic cell-laden embedding medium
Source abstract
Abstract
Abstract Constructing an in vitro vascularized liver tissue model that closely simulates the human liver is crucial for promoting cell proliferation, mimicking physiological heterogeneous structures, and recreating the cellular microenvironment. However, the layer-by-layer printing method is significantly constrained by the rheological properties of the bioink, making it challenging to form complex three-dimensional vascular structures in low-viscosity soft materials. To overcome this limitation, we developed a cross-linkable biphasic embedding medium by mixing low-viscosity biomaterials with gelatin microgel. This medium possesses yield stress and self-healing properties, facilitating efficient and continuous three-dimensional shaping of sacrificial ink within it. By adjusting the printing speed, we controlled the filament diameter, achieving a range from 250 μm to 1000 μm, and ensuring precise control over ink deposition locations and filament shapes. Using the in situ endothelialization method, we constructed complex vascular structures and ensured close adhesion between hepatocytes and endothelial cells. In vitro experiments demonstrated that the vascularized liver tissue model exhibited enhanced protein synthesis and metabolic function compared to mixed liver tissue. We also investigated the impact of varying vascular densities on liver tissue function. Transcriptome sequencing revealed that liver tissues with higher vascular density exhibited upregulated gene expression in metabolic and angiogenesis-related pathways. In summary, this method is adaptable to various materials, allowing the rheological properties of the supporting bath and the tissue’s porosity to be modified using microgels, thus enabling precise regulation of the liver tissue microenvironment. Additionally, it facilitates the rapid construction of three-dimensional vascular structures within liver tissue. The resulting vascularized liver tissue model exhibits enhanced biological functionality, opening new opportunities for biomedical applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Liver sinusoidal endothelial cells—gatekeepers of hepatic immunity10.1038/s41575-018-0020-y ↗
2. Human biomimetic liver microphysiology systems in drug development and precision medicine10.1038/s41575-020-00386-1 ↗
3. The global burden of liver disease: the major impact of China10.1002/hep.27406 ↗
4. Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing10.1186/s13287-021-02152-9 ↗
5. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment10.1016/j.biomaterials.2022.121575 ↗
6. 3D-bioprinted cholangiocarcinoma-on-a-chip model for evaluating drug responses10.1007/s42242-022-00229-9 ↗
7. Current advances on 3D-bioprinted liver tissue models10.1002/adhm.202001517 ↗
8. The hepatic microvascular system in health and its response to toxicants10.1002/ar.20663 ↗
9. Vascularization and angiogenesis in tissue engineering: beyond creating static networks10.1016/j.tibtech.2016.03.002 ↗
10. In vitro strategies to vascularize 3D physiologically relevant models10.1002/advs.202100798 ↗
11. From arteries to capillaries: approaches to engineering human vasculature10.1002/adfm.201910811 ↗
12. Recent advances in biofabrication strategies based on bioprinting for vascularized tissue repair and regeneration10.1016/j.matdes.2023.111885 ↗
13. Constructing biomimetic liver models through biomaterials and vasculature engineering10.1093/rb/rbac079 ↗
14. Progress in 3D bioprinting technology for tissue/organ regenerative engineering10.1016/j.biomaterials.2019.119536 ↗
15. 3D bioprinting for biomedical devices and tissue engineering: a review of recent trends and advances10.1016/j.bioactmat.2017.11.008 ↗
16. Directly coaxial 3D bioprinting of large-scale vascularized tissue constructs10.1088/1758-5090/ab7e76 ↗
17. Perfusable vessel-on-a-chip for antiangiogenic drug screening with coaxial bioprinting10.18063/ijb.v8i4.619 ↗
18. Dual-core coaxial bioprinting of double-channel constructs with a potential for perfusion and interaction of cells10.1088/1758-5090/ac6e88 ↗
19. Spheroid on-demand printing and drug screening of endothelialized hepatocellular carcinoma model at different stages10.1088/1758-5090/ace3f9 ↗
20. Three-dimensional fabrication of thick and densely populated soft constructs with complex and actively perfused channel network10.1016/j.actbio.2017.10.047 ↗
21. 3D bioprinting microgels to construct implantable vascular tissue10.1111/cpr.13456 ↗
22. 3D liver tissue model with branched vascular networks by multimaterial bioprinting10.1002/adhm.202101405 ↗
23. Extracellular matrix requirements for gastrointestinal organoid cultures10.1016/j.biomaterials.2021.121020 ↗
24. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids10.1016/j.stem.2021.04.005 ↗
25. Liver stiffness: a novel parameter for the diagnosis of liver disease10.2147/HMER.S7394 ↗
26. Collagen characterization in a model of nonalcoholic steatohepatitis with fibrosis; a call for development of targeted therapeutics10.3390/molecules26113316 ↗
27. Recent advances on bioengineering approaches for fabrication of functional engineered cardiac pumps: a review10.1016/j.biomaterials.2021.121298 ↗
28. 3D bioprinting of tissues and organs10.1038/nbt.2958 ↗
29. Production of multiple cell-laden microtissue spheroids with a biomimetic hepatic-lobule-like structure10.1002/adma.202102624 ↗
30. 3D printing of cell-laden microgel-based biphasic bioink with heterogeneous microenvironment for biomedical applications10.1002/adfm.202109810 ↗
31. Regulable supporting baths for embedded printing of soft biomaterials with variable stiffness10.1021/acsami.2c09221 ↗
32. Simultaneous multi-material embedded printing for 3D heterogeneous structures10.1088/2631-7990/acd285 ↗
33. 3D bioprinting of collagen to rebuild components of the human heart10.1126/science.aav9051 ↗
34. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels10.1126/sciadv.aaw2459 ↗
35. Expanding embedded 3D bioprinting capability for engineering complex organs with freeform vascular networks10.1002/adma.202205082 ↗
36. Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels10.1126/sciadv.1500758 ↗
37. Advanced strategies in the application of gelatin- based bioink for extrusion bioprinting10.1007/s42242-023-00236-4 ↗
38. Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis10.1111/liv.14726 ↗
39. Reference values of normal liver stiffness in healthy children by two methods: 2D shear wave and transient elastography10.1038/s41598-020-64320-w ↗
40. Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system10.1016/j.biomaterials.2012.02.054 ↗
41. Maintenance of primary hepatocyte functions in vitro by inhibiting mechanical tension-induced YAP activation10.1016/j.celrep.2019.10.128 ↗
42. High-throughput production of liver parenchymal microtissues and enrichment of organ-specific functions in gelatin methacrylamide microenvironment10.1002/bit.28010 ↗
43. A liver-on-a-chip platform with bioprinted hepatic spheroids10.1088/1758-5090/8/1/014101 ↗
44. Mimicking native liver lobule microarchitecture in vitro with parenchymal and non-parenchymal cells using 3D bioprinting for drug toxicity and drug screening applications10.1021/acsami.2c00312 ↗
45. Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A410.3389/fphar.2024.1404938 ↗
46. Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress10.1038/s41467-024-46135-9 ↗
47. α1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy10.1172/JCI0216782 ↗
48. Cytochrome P450 enzymes and drug metabolism in humans10.3390/ijms222312808 ↗
49. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis10.1038/nrc2015 ↗
50. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention10.1021/cr200085w ↗
51. Basement membranes: structure, assembly and role in tumour angiogenesis10.1038/nrc1094 ↗
52. Brief exposure to novel or enriched environments reduces sucrose cue-reactivity and consumption in rats after 1 or 30 days of forced abstinence from self-administration10.1371/journal.pone.0054164 ↗
53. Eicosanoids and cancer10.1038/nrc2809 ↗